The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
SOCIETY: AGA This session will explore the complex dynamics between the gut microbiome and immune checkpoint inhibitors, addressing whether specific microbes/metabolites enhance therapeutic outcomes acting as allies or present challenges as potential foes, impacting treatment efficacy and associate…
SOCIETY: AGA In this session, presenters will provide insights into pioneering nutrition interventions and microbiome modulation strategies from studies that span both pediatric and adult patients…
SOCIETY: AGA The session will highlight the current state of microbiome therapeutics, the challenges with developing and testing them in humans and the outlook for future of microbiome therapies beyond FMT…